LAS VEGAS, Nov. 3 /PRNewswire-FirstCall/ -- VMT Scientific Inc. (OTC:VMTF) After extensive meetings and discussions with top medical researchers Jacques D. Barth, MD, PhD, FACC, FAHA and M. Arthur Charles MD, PhD, we are anticipating them to execute an agreement that would place VMT Scientific, Inc. on track to begin Clinical Trials. We are pleased that both doctors were able to conclude proper due-diligence and evaluate the potential of the VasCir(TM) device. Understanding the emotional value and medical benefits our product brings to all Diabetics suffers of PVD, we are pleased to be able to have VasCir(TM) reviewed by such renowned Doctors and receive their objective opinions. VMT Scientific, Inc. is hoping to have signed agreements from both Dr. Barth and Dr. Charles on or before Monday, November 7th 2005. Please visit our web site at http://www.vmtf.com/. This Press Release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward- looking statements, particularly those risks and uncertainties inherent in the process of developing, manufacturing and distributing medical products and Clinical trials. Factors that may cause such a difference include risks related to VMT Scientific Inc.'s limited operating history, risks associated with completing development and obtaining FDA medical approvals, successful patent protection and prosecution, successful sale of licensed technology nationally or internationally. VMT Scientific technology will not meet with market acceptance, the risk of future warranty and product liability claims, the uncertainty of VMT Scientific Inc.'s future access to capital to sustain operations, achieve profitability or continue as a going concern, the failure by VMT Scientific Inc.'s to secure and maintain relationships with suppliers, manufacturers and other third parties, reliance on key employees, and dependence on intellectual property. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. DATASOURCE: VMT Scientific, Inc. CONTACT: Catherine S. Ratelle, Director of Operations, VMT Scientific, Inc., +1-702-990-3477, Web site: http://www.vmtf.com/

Copyright